Etiology of pulmonary infections in predominantly HIV-infected adults with suspected tuberculosis, Botswana

International Journal of Tuberculosis and Lung Disease

Volumn 7, Issue 8, 2003, Pages 714-723

  Lockman, Shahin ^a,b,c   Hone, N ^d   Kenyon, T A ^b   Mwasekaga, M ^e   Villauthapillai, M ^f   Creek, T ^b,c   Zell, E ^g   Kirby, A ^g   Thacker, W L ^g   Talkington, D ^g   Moura, I N ^c   Binkin, N J ^c   Clay, L ^b   Tappero, J W ^a,c,h  

^a HARVARD SCHOOL OF PUBLIC HEALTH   (United States)

^b BOTUSA Project   (Botswana)

^c CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

^d Nyangabgwe Hospital   (Botswana)

^e National TB Reference Laboratory   (Botswana)

^f National Health Laboratory   (Botswana)

^g NATIONAL CENTER FOR EMERGING AND ZOONOTIC INFECTIOUS DISEASES   (United States)

^h Centers for Dis Ctrl Prevention   (Thailand)

Author keywords

Botswana, Africa; HIV; Mycoplasma pneumoniae; Respiratory disease diagnosis; Smear negative tuberculosis

Indexed keywords

ABDOMINAL RADIOGRAPHY; ADULT; ARTICLE; BOTSWANA; CONTROLLED STUDY; FEMALE; HOSPITALIZATION; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; HUMAN IMMUNODEFICIENCY VIRUS PREVALENCE; LUNG INFECTION; MAJOR CLINICAL STUDY; MALE; MYCOPLASMA PNEUMONIA; PNEUMOCYSTIS CARINII; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; THORAX RADIOGRAPHY; TUBERCULOSIS;

ADULT; ANTIBIOTICS, ANTITUBERCULAR; BOTSWANA; CROSS-SECTIONAL STUDIES; FEMALE; HIV INFECTIONS; HIV-1; HUMANS; MALE; MYCOBACTERIUM TUBERCULOSIS; PNEUMONIA, MYCOPLASMA; POLYMERASE CHAIN REACTION; PREVALENCE; SPUTUM; TRIMETHOPRIM-SULFAMETHOXAZOLE COMBINATION; TUBERCULOSIS, PULMONARY;

EID: 0042662582     PISSN: 10273719     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (68)

1. Selwyn P A, Hartel D, Lewis V A, et al. A prospective study of the risk of tuberculosis among intravenous drug users with HIV. N Engl J Med 1989; 320: 545-550.
2. Burwen D R, Bloch A B, Griffin L D, Ciesielski C A, Stern H A, Onorato I M. National trends in the concurrence of tuberculosis and acquired immunodeficiency syndrome. Arch Int Med 1995; 155: 1281-1286.
3. Sepkowitz K A, Raffalli J, Riley L, Kiehn T E, Armstrong D. Tuberculosis in the AIDS era. Clin Micro Rev 1995; 8: 180-199.
4. Raviglione M C, Snider D E, Kochi A. Global epidemiology of tuberculosis morbidity and mortality of a worldwide epidemic. JAMA 1995; 273: 220-226.
5. Narain J P, Raviglione M C, Kochi A. HIV-associated tuberculosis in developing countries: epidemiology and strategies for prevention. Tubercle Lung Dis 1992; 73: 311-321.
6. Eriki P P, Okwera A, Aisu T, Morrissey A B, Ellner J J, Daniel T M. The influence of human immunodeficiency virus infection on tuberculosis in Kampala, Uganda. Am Rev Respir Dis 1991; 143: 185-187.
7. Elliott A M, Luo N, Tembo G, et al. Impact of HIV on tuberculosis in Zambia: a cross-sectional study. BMJ 1990; 301: 412-415.
8. DeCock K M, Gnaore E, Adjorlolo G, et al. Risk of tuberculosis in patients with HIV-1 and HIV-2 infections in Abidjan, Ivory Coast. BMJ 1991; 302: 496-499.
9. Lucas S B, Hounnou A, Peacock C, et al. The mortality and pathology of HIV infection in a West African city. AIDS 1993; 7: 1569-1579.
10. Abouya Y L, Beaumel A, Lucas S, et al. Pneumocystis carinii pneumonia: an uncommon cause of death in African patients with the acquired immunodeficiency syndrome. Am Rev Respir Dis 1992; 145: 617-620.
11. Batungwanayo J, Taelman H, Lucas S, et al. Pulmonary disease associated with the human immunodeficiency virus in Kigali, Rwanda: a fiberoptic bronchoscopic study of 111 cases of undetermined etiology. Am J Respir Crit Care Med 1994; 149: 1591-1596.
12. Kamanfu G, Mlika-Cabanne N, Girard P M, et al. Pulmonary complications of human immunodeficiency virus infection in Bujumbura, Burundi. Am Rev Respir Dis 1993; 147: 658-663.
13. Grant A D, Sidibe K, Domoua K, et al. Spectrum of disease among HIV-infected adults hospitalized in a respiratory medicine unit in Abidjan, Cote d'Ivoire. Int J Tuberc Lung Dis 1998; 2: 926-934.
14. Mwachari C W, Cohen C R, Meier A S, Nganga L W, Kimari J N, Odhiambo J A. Respiratory tract infection in HIV-1-infected adults in Nairobi, Kenya: evaluation of risk factors and the world health organization treatment algorithm. J Acquir Immune Defic Syndr 2001; 27: 365-371.
15. Carme B, Mboussa J, Andzin M, Mbouni E, Mpele P, Datry A. Pneumocystis carinii is rare in AIDS in Central Africa. Trans R Soc Trop Med Hyg 1991; 85: 80.
16. Elvin K M, Lumbwe C M, Luo N P, Bjorkman A, Kallenius G, Linder E. Pneumocystis carinii is not a major cause of pneumonia in HIV-infected patients in Lusaka, Zambia. Trans Roy Soc Trop Med Hyg 1989; 83: 553-555.
17. Hargreaves N J, Kadzakumanja O, Phiri S, et al. Pneumocystis carinii pneumonia in patients being registered for smear-negative pulmonary tuberculosis in Malawi. Trans R Soc Trop Med Hyg 2001; 95: 402-408.
18. Malin A S, Gwanzura L K, Klein S, Robertson V J, Musvaire P, Mason P R. Pneumocystis carinii pneumonia in Zimbabwe. Lancet 1995; 346: 1258-1261.
19. Harries A D, Maher D, Nunn P. An approach to the problems of diagnosing and treating adult smear-negative pulmonary tuberculosis in high-HIV-prevalence settings in sub-Saharan Africa. Bull World Health Organ 1998; 76: 661-662.
20. Elliott A M, Namaambo K, Allen B W, et al. Negative sputum smear results in HIV-positive patient with pulmonary tuberculosis in Lusaka, Zambia. Tubercle Lung Dis 1993; 74: 191-194.
21. Hawken M P, Muhindi D W, Chakaya J M, Bhatt S M, Ng'ang'a L W, Porter J D. Under-diagnosis of smear-positive pulmonary tuberculosis in Nairobi, Kenya. Int J Tuberc Lung Dis 2001; 5: 360-363.
22. Hargreaves N J, Kadzakumanja O, Phiri S, et al. What causes smear-negative pulmonary tuberculosis in Malawi, an area of high HIV seroprevalence? Int J Tuberc Lung Dis 2001; S: 113-122.
23. Wilkinson D, Newman W, Reid A, Squire S B, Sturm A W, Gilks C F. Trial-of-antibiotic algorithm for the diagnosis of tuberculosis in a district hospital in a developing country with high HIV prevalence. Int J Tuberc Lung Dis 2000; 4: 513-518.
24. Epidemiology Section, Botswana National Tuberculosis Program. 1989 Annual Report. Gaborone, Botswana: Ministry of Health, 1989.
25. Epidemiology Section, Botswana National Tuberculosis Program. 1999 Annual Report. Gaborone, Botswana: Ministry of Health, 1999.
26. National AIDS Coordinating Agency, Botswana Ministry of Health. Sentinel HIV Surveillance 2000. Gaborone, Botswana; NACA, 2000.
27. Messmer T O, Skelton S K, Moroney J F, Daugharty H, Fields B S. Application of nested, multiplex PCR to psittacosis outbreaks. J Clin Microbiol 1997; 35: 2043-2046.
28. Bernet C, Garret M, de Barbeyrac B, Bebear C, Bonnet J. Detection of Mycoplasma pneumoniae by using the polymerase chain reaction. J Clin Microbiol 1989; 27: 2492-2496.
29. Wood E, Cheong I, Lee C. A study of chest infections in HIV seropositive patients in Kuala Lumpur. Int J Clin Pract 1998; 52: 23-26.
30. Samb B, Sow P S, Kony S, et al. Risk factors for negative sputum acid-fast bacilli smears in pulmonary tuberculosis: results from Dakar, Senegal, a city with low HIV seroprevalence. Int J Tuberc Lung Dis 1999; 3: 330-336.
31. Elliott A M, Halwiindi B, Hayes R J, et al. The impact of HIV on presentation and diagnosis in a cohort study in Zambia. J Trop Med Hyg 1993; 96: 1-11.
32. Johnson J L, Vjecha M J, Okwera A, et al. Impact of HIV type-1 infection on the initial bacteriologic and radiographic manifestations of pulmonary tuberculosis in Uganda. Int J Tuberc Lung Dis 1998; 2: 397-404.
33. Githui W, Nunn P, Juma E, et al. Cohort study of HIV-positive and HIV-negative tuberculosis, Nairobi, Kenya: comparison of bacteriological results. Tubercle Lung Dis 1992; 73: 203-209.
34. Tshibwabwa-Tumba E, Mwinga A, Pobee J O, Zumla A. Radiological feature of pulmonary tuberculosis in 963 HIV-infected adults at three Central African hospitals. Clin Radiol 1997; 52: 837-841.
35. Haramati L B, Jenny-Avital E R, Altermann D D. Effect of HIV status on chest radiographic and CT findings in patients with tuberculosis. Clin Radiol 1997; 52: 31-35.
36. Tattevin P, Casalino E, Fleury L, Egmann G, Ruel M, Bouvet E. The validity of medical history, classic symptoms, and chest radiographs in predicting pulmonary tuberculosis: derivation of a pulmonary tuberculosis prediction model. Chest 1999; 115: 1248-1253.
37. Samb B, Henzel D, Daley C L, et al. Methods for diagnosing tuberculosis among in-patients in eastern Africa whose sputum smears are negative. Int J Tuberc Lung Dis 1997; 1: 25-30.
38. Nelson S M, Deike M A, Cartwright C P. Value of examining multiple sputum specimens in the diagnosis of pulmonary tuberculosis. J Clin Microbiol 1998; 36: 467-469.
39. Parry C M, Kamoto O, Harries A D, et al. The use of sputum induction for establishing a diagnosis in patients with suspected pulmonary tuberculosis in Malawi. Tubercle Lung Dis 1995; 76: 72-76.
40. Cohen R A, Muzaffar S, Schwartz D, et al. Diagnosis of pulmonary tuberculosis using PCR assays on sputum collected within 24 hours of hospital admission. Am J Respir Crit Care Med 1998; 157: 156-161.
41. Eing B R, Becker A, Sohns A, Ringelmann R. Comparison of Roche Cobas Amplicor Mycobacterium tuberculosis assay with in-house PCR and culture for detection of M. tuberculosis. J Clin Microbiol 1998; 36: 2023-2029.
42. Devallois A, Legrand E, Rastogi N. Evaluation of Amplicor MTB test as adjunct to smears and culture for direct detection of Mycobacterium tuberculosis in the French Caribbean. J Clin Microbiol 1996; 34: 1065-1068.
43. Moore D F, Curry J I. Detection and identification of Mycobacterium tuberculosis directly from sputum sediments by Amplicor PCR. J Clin Microbiol 1995; 33: 2686-2691.
44. Tan M F, Ng W C, Chan S H, Tan W C. Comparative usefulness of PCR in the detection of Mycobacterium tuberculosis in different clinical specimens. J Med Microbiol 1997; 46: 164-169.
45. Bogard M, Vincelette J, Antinozzi R, et al. Multicenter study of a commercial, automated polymerase chain reaction system for the rapid detection of Mycobacterium tuberculosis in respiratory specimens in routine clinical practice. Eur J Clin Microbiol Infect Dis 2001; 20: 724-731.
46. Marrie T J, Peeling R W, Fine M J, Singer D E, Coley C M, Kapoor W N. Ambulatory patients with community-acquired pneumonia: the frequency of atypical agents and clinical course. Am J Med 1996; 101: 508-515.
47. Lieberman D, Schlaeffer F, Lieberman D, Horowitz S, Horovitz O, Porath A. Mycoplasma pneumoniae community-acquired pneumonia: a review of 101 hospitalized adult patients. Respiration 1996; 63: 261-266.
48. Tarp B, Jensen J S, Ostergaard L, Andersen P L. Search for agents causing atypical pneumonia in HIV-positive patients by inhibitor-controlled PCR assays. Eur Respir J 1999; 13: 175-179.
49. Cultrera R, Roulland-Dussoix D, Romani R, Contini C. Use of PCR to detect mycoplasma DNA in respiratory tract specimens from adult HIV-positive patients. J Med Microbiol 1998; 47: 983-986.
50. Park D R, Sherbin V L, Goodman M S, et al. The etiology of conmmnity-acquired pneumonia at an urban public hospital: influence of human immunodeficiency virus infection and initial severity of illness. J Infect Dis 2001; 184: 268-277.
51. Khoo S H, Hajia M, Storey C C, et al. Influenza-like episodes in HIV-positive patients: the role of viral and "atypical" infections. AIDS 1998; 12: 751-757.
52. Teel L D, Finelli M R, Johnson S C. Isolation of Mycoplasma species from bronchoalveolar lavages of patients positive and negative for human immunodeficiency virus. J Clin Microbiol 1994; 32: 1387-1389.
53. Thacker W L, Talkington D F. Analysis of complement fixation and commercial enzyme immunoassays for detection of antibodies to Mycoplasma pneumoniae in human serum. Clin Diagn Lab Immunol 2000; 7: 778-780.
54. Petitjean J, Vabret A, Gouarin S, Freymuth F. Evaluation of four commercial immunoglobulin G (IgG)- and IgM-specific enzyme immunoassays for diagnosis of Mycoplasma pneumoniae infections. J Clin Microbiol 2002; 40: 165-171.
55. Waris M E, Toikka P, Saarinen T, et al. Diagnosis of Mycoplasma pneumoniae pneumonia in children. J Clin Microbiol 1998; 36: 3155-3159.
56. Cimolai N, Cheong A C. An assessment of a new diagnostic indirect enzyme immunoassay for the detection of anti-Mycoplasma pneumoniae IgM. Am J Clin Pathol 1996; 105: 205-209.
57. Uldum S A, Jensen J S, Sondergard-Andersen J, Lind K. Enzyme immunoassay for detection of immunoglobulin M (IgM) and IgG antibodies to Mycoplasma pneumoniae. J Clin Microbiol 1992; 30: 1198-1204.
58. Dorigo-Zetsma J W, Zaat S A, Wertheim-van Dillen P M, et al. Comparison of PCR, culture, and serological tests for diagnosis of Mycoplasma pneumoniae respiratory tract infection in children. J Clin Microbiol 1999; 37: 14-17.
59. Abele-Horn M, Busch U, Nitschko H, et al. Molecular approaches to diagnosis of pulmonary diseases due to Mycoplasma pneumoniae. J Clin Microbiol 1998; 36: 548-551.
60. E Jacobs. Serological diagnosis of Mycoplasma pneumoniae infections: a critical review of current procedures. Clin Infect Dis 1993; 17 Suppl 1: S79-S82.
61. Nadala D, Bossart W, Zucol F, et al. Community-acquired pneumonia in children due to Mycoplasma pneumoniae: diagnostic performance of a seminested 16S rDNA-PCR. Diagn Microbiol Infect Dis 2001; 39: 15-19.
62. Wadowsky R M, Castilla E A, Laus S, et al. Evaluation of Chlamydia pneumoniae and Mycoplasma pneumoniae as etiologic agents of persistent cough in adolescents and adults. J Clin Microbiol 2002; 40: 637-640.
63. Dorigo-Zetsma J W, Verkooyen R P, van Helden H P, van der Nat H, van den Bosch J M. Molecular detection of Mycoplasma pneumoniae in adults with community-acquired pneumonia requiring hospitalization. J Clin Microbiol 2001; 39: 1184-1186.
64. Hauksdottir G S, Jonsson T, Sigurdardottir V, Love A. Seroepidemiology of Mycoplasma pneumoniae infections in Iceland 1987-96. Scand J Infect Dis 1998; 30: 177-180.
65. Dorigo-Zetsma J W, Wilbrink B, van der Nat H, Bartelds A I, Heijnen M L, Dankert J. Results of molecular detection of Mycoplasma pneumoniae among patients with acute respiratory infection and in their household contacts reveals children as human reservoirs. J Infect Dis 2001; 183: 675-678.
66. Koulla-Shiro S, Kuaban C, Belec L. Microbial etiology of acute community-acquired pneumonia in adult hospitalized patients in Yaounde-Camerooon. Clin Microbiol Infect 1997; 3: 180-186.
67. Toikka P, Juven T, Virkki R, Leinonen M, Mertsola J, Ruuskanen O. Streptococcus pneumoniae and Mycoplasma pneuomoniae coinfection in community acquired pneumonia. Arch Dis Child 2000; 83: 413-414.
68. Tan M J, Tan J S, File T M. Legionnaires disease with bacteremic coinfection. Clin Infect Dis 2002; 35: 533-539.